View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Macro Vision: Sector Synopsis

STRATEGY We are upgrading our outlook on the S&P 500 from neutral to bullish following last week's weekly close above 5783. We previously downgraded our outlook to neutral in our 8/6/24 Compass, after being bullish since early-November 2023, noting that we expected a 1- to 4-month consolidation phase with support coming-in at 5100-5191. Since late-August we have expected 5670-5783 to cap upside on the S&P 500, noting that we would go where the market takes us, i.e., upgrade to bullish on a break...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

U.S. Dollar (DXY), 10-Yr Treasury Yield Rolling Over Large-caps (SPY, QQQ, DIA) remain bullish, mid-caps (IJH) are starting to outperform, and small-caps (IWM, IJR) are finally breaking out from major 2-year bases. Market generated information continues to tell us that a resurgence on the inflation front is unlikely; the 10-year Treasury yield has not been able to break above major 4.35% resistance and appears to be rolling over, while mid-caps are starting to outperform (and potentially small-...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

WIX WIX.COM LTD.
TWOU 2U INC.
TGTX TG THERAPEUTICS INC.
SMG SCOTTS MIRACLE-GRO COMPANY CLASS A
SGMO SANGAMO THERAPEUTICS INC.
RRC RANGE RESOURCES CORPORATION
RP REALPAGE INC.
RNG RINGCENTRAL INC. CLASS A
RGR STURM RUGER & COMPANY INC.
RGEN REPLIGEN CORPORATION
PSX PHILLIPS 66
PRLB PROTO LABS INC.
NERV MINERVA NEUROSCIENCES
NBIX NEUROCRINE BIOSCIENCES INC.
MRTX MIRATI THERAPEUTICS INC.
MPWR MONOLITHIC POWER SYSTEMS INC.
MKC MCCORMICK & COMPANY INCORPORATED
LOPE GRAND CANYON EDUCATION INC.
JKHY JACK HENRY & ASSOCIATES INC.
IPHI INPHI CORPORATION
IPGP IPG PHOTONICS CORPORATION
IIVI II-VI INCORPORATED
GWPH GW PHARMACEUTICALS PLC SPONSORED ADR
FTNT FORTINET INC.
FAST FASTENAL COMPANY
EXEL EXELIXIS INC.
CYTK CYTOKINETICS INCORPORATED
CTMX CYTOMX THERAPEUTICS INC.
BOX BOX INC. CLASS A
BMY BRISTOL-MYERS SQUIBB COMPANY
BGS B&G FOODS INC.
ATRC ATRICURE INC.
ALRM ALARM.COM HOLDINGS INC.
ABMD ABIOMED INC.
SHW SHERWIN-WILLIAMS COMPANY
AEM. AGNICO EAGLE MINES LIMITED
OR OSISKO GOLD ROYALTIES LTD
ENPH ENPHASE ENERGY INC.
LSCC LATTICE SEMICONDUCTOR CORPORATION
SAM BOSTON BEER COMPANY INC. CLASS A
CENTA CENTRAL GARDEN & PET CO A
MRAM EVERSPIN TECHNOLOGIES
COUP COUPA SOFTWARE INC.
NTLA INTELLIA THERAPEUTICS INC.
AXON AXON ENTERPRISE INC
NOMDN NOMAD FOODS LTD.
MDGL MADRIGAL PHARMACEUTICALS
OKTA OKTA INC. CLASS A
KALA KALA PHARMACEUTICALS INC.
BAND BANDWIDTH CLASS A
ACMR ACM RESEARCH
AVYA AVAYA HOLDINGS
SPY SPDR S&P 500 ETF
AZN ASTRAZENECA PLC ADS
DBX DROPBOX INC. CLASS A
LASR NLIGHT
LQDA LIQUIDIA CORPORATION
CNST CONSTELLATION PHARMACEUTICALS
ESTC ELASTIC N.V.
ARAV ARAVIVE
NGM NGM BIOPHARMACEUTICALS
NIU NIU TECHNOLOGIES ADS (N SHARES)
PD PAGERDUTY
BYND BEYOND MEAT
SCPL SCIPLAY
AVTR AVANTOR INC.
FSLY FASTLY
BSGM BIOSIG TECHNOLOGIES INC
UI UBIQUITI INC.
PSN PARSONS
NVAX NOVAVAX INC.
CRNC CERENCE
DDOG DATADOG INC CLASS A
LVGO LIVONGO HEALTH
FVRR FIVERR INTERNATIONAL
AQST AQUESTIVE THERAPEUTICS
TWST TWIST BIOSCIENCE
ADPT ADAPTIVE BIOTECHNOLOGIES CORP.
REYN REYNOLDS CONSUMER PRODUCTS
SDGR INC.
SCHRÖDINGER
INC.
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

Bullish Developments Continue; Downgrading Communications Bullish developments continue to flood the market, leading us to believe we may be in the early stages of a broad-based advance. • Bullish Arguments Flooding the Market. Major global and US indexes (SPY, RSP, QQQ, EEM, EFA, EUFN, ACWI, Europe, Japan, etc.) are making bullish inflections. Serial laggards such as retail (XRT) and biotech (IBB, XBI) appear to be bottoming. Cyclical Sectors are breaking topside resistance (e.g., XLK, XLF,...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

The S&P 500 managed to close above the key 2,817 resistance level last week as the recovery from 4Q2018 continues. We would like to see a more decisive upside move and for the index stay above this level for a few more days before calling it an official breakout. Overall we remain positive and continue to believe a “buy the dip” strategy is warranted. Below we highlight several observations which lead us to our positive outlook: • An offensive Sector shift: We are upgrading Materials (RTM...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

S&P 500 at new all-time highs with uptrend intact Risk-on. The S&P 500 has surpassed the January all-time high, staying above this level for over a week. What's more important is the 5-month uptrend remains intact and cyclical/risk-on areas are reasserting their leadership status. Think technology, discretionary, and biotech/medical devices - all current overweights. At the same time, defensive areas have petered out in terms of relative strength, exactly what we want to see in a healthy bull m...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

YTD S&P 500 trading range continues; Avoid broad international exposure Constructive but murky outlook for U.S. equities paints an overall mixed picture, making sector/group/stock selection critical. • Bull case: (1) advance-decline (A-D) lines and other breadth indicators (% of stocks above 50-, 200-day moving averages) are neutral to positive; (2) price and RS uptrends remain intact for risk-on segments, including Technology (XLK), biotech (XBI, IBB), and growth stocks (IUSG); and (3) the ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Macro Vision: U.S. Equity Strategy

The last several months have been that of digestion and consolidation. While Sector and group leadership have taken a back seat to stock selection, rotations still seem to be the norm. We have on a number of occasions indicated that the current rotations are reminiscent of the rotations of 1994. Bill Clinton was President and in that year the Republicans had swept the house under their “Contract with America”. Clinton had imposed tariffs on steel imports late in 1993 and with the onslaugh...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

Upgrading Consumer Discretionary; Outlook increasingly bullish Upgrading Consumer Discretionary. The XLY's price and relative strength are breaking topside resistance to new highs... see below (right) and page 5. Market outlook and internals. Market internals continue to improve, which bolsters our increasingly bullish outlook. The Cyclicals vs. Staples ratio (XLY/XLP) continues to advance to new highs, confirming a risk-on environment. Also, one of the few previously concerning indicators we'...

USO UNITED STATES OIL FUND LP
SLV ISHARES SILVER TRUST
GLD SPDR GOLD TRUST
XLB MATERIALS SELECT SECTOR SPDR FUND
EEM ISHARES MSCI EMERGING MARKETS ETF
EWC ISHARES MSCI CANADA ETF
IWM ISHARES RUSSELL 2000 INDEX FUND
IAU ISHARES COMEX GOLD TRUST
EWQ ISHARES MSCI FRANCE ETF
EIRL ISHARES MSCI IRELAND CAPPED ET
MCHI.. ISHARES MSCI CHN
XLV SELECT SECTOR SPDR-HEALTH CARE
XLP SELECT SECTOR SPDR-CONSUMER STAPLES
XLY SELECT SECTOR SPDR-CONSUMER DISCRETIONARY
XLE SELECT SECTOR SPDR-ENERGY
XLF SELECT SECTOR SPDR-FINANCIAL
XLI SELECT SECTOR SPDR-INDUSTRIAL
XLK SELECT SECTOR SPDR-TECHNOLOGY
XLRE REAL ESTATE SPDR
XLU SELECT SECTOR SPDR-UTILITIES
THD. ISHARES MSCI THAILAND CAPPED E
SOXX ISHARES PHLX SEMICONDUCTOR ETF
ENZL ISHARES MSCI NEW ZEALAND CAPPE
SMH MARKET VECTORS SMEICONDOUCTOR ETF
SPY SPDR S&P 500 ETF
EFA ISHARES TRUST MSCI EAFE INDEX FUND
BNO US BRENT OIL FUND LP
A2AMMR PUREFUNDS ISE MOBILE PAYMENTS ETF
SCZ ISHARES MSCI EAFE SMALL-CAP ET
EPU ISHARES MSCI ALL PERU CAPPED E
ENOR ISHARES MSCI NORWAY CAPPED ETF
EWU SPDR S&P OIL & GAS EXPLORATION ETF
XOP ISHARES NORTH AMERICAN TECH-SOFTWARE ETF
IGV BLACKROCK INSTITUTIONAL TRUST COMPANY N.A.
EWS SPDR S&P SOFTWARE AND SERVICES FUND
XSW SPDR KBW REGIONAL BANKING ETF
KRE. VANECK VECTORS OIL REFINERS ETF
CRAK INVESCO DB COMMODITY INDEX TRACKING FUND
DBC INVESCO DB OIL FUND
DBO ISHARES MSCI HONG KONG ETF
EWH ISHARES U.S. OIL & GAS EXPLORA
IEO ISHARES MSCI FINLAND CAPPED INVESTABLE MARKET INDEX FUND
EFNL ISHARES MSCI JAPAN ETF
EWJ SPDR S&P RETAIL ETF
XRT MARKET VECTORS RETAIL ETF
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

Upgrading Utilities; Downgrading Industrials • Utilities upgrade, Industrials downgrade. Utilities' price and relative strength trends have been hitting higher lows and higher highs since the market bottomed in February, justifying an upgrade to market weight... see below and page 7. As for Industrials, the XLI's price and relative strength trends have continued to deteriorate, prompting us to downgrade the sector to market weight... see below and page 8. • Big picture trends: Commodities ...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - 2018 04 25

LIN:DEU currently trades near historical highs relative to UAFRS-based (Uniform) Assets, with a 1.6x Uniform P/B. At these levels, the market is pricing in expectations for Uniform ROA to increase from 6% in 2017 to record-high 8% levels in 2022, accompanied by immaterial Uniform Asset growth going forward. Analysts have similar expectations, projecting Uniform ROA to improve to 7% by 2019, accompanied by 1% Uniform Asset shrinkage. However, Valens' qualitative analysis of the firm's Q4 2017 ear...

Valens Research
  • Valens Research

SPY - Embedded Expectations Analysis - 2018 04 19

The SPY currently trades at levels in line with pre-recession valuations relative to UAFRS-based (Uniform) Earnings, with a 20.1x Uniform P/E (Fwd V/E′). At these valuations, market expectations are for sustained profitability in line with recent trends, suggesting reasons to believe the fund is likely fairly valued at worst, with the potential for upside should growth improve going forward S&P 500 companies have seen Uniform ROA (ROA') plateau around 13% levels since 2010. While profitabilit...

Valens Research
  • Valens Research

SPY - Embedded Expectations Analysis - 2018 03 28

 The SPY currently trades at levels relative to UAFRS-based (Uniform) Earnings not seen since 2001, with a 23.7x Uniform P/E (V/E'). Expectations initially appear high, with the market expecting Uniform ROA (ROA') to sustain at forecasted peak 28% levels, with 6% Uniform Asset growth (Asset' growth), however upon deeper review, expectations do not appear unreasonable  S&P companies have consistently improved ROA' every year since 2002, seeing ROA' rise from 13% then, to 26% in 2016, and ...

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch